Join
Live feed
·
INSIDERFilingvia Quantisnow
Climb Bio Inc. logo

President and CEO Brennan Aoife converted options into 68,750 shares and sold $406,979 worth of shares (30,902 units at $13.17) as part of a pre-agreed trading plan, increasing direct ownership by 76% to 87,731 units (SEC Form 4) (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLYM (Climb Bio Inc.) and more on Quantisnow.